Werewolf Therapeutics
Patents, Design & Utilities

Last updated:

List of all Werewolf Therapeutics patents 11 in total

Status Patent
Application
Utility: SEPARATION MOIETIES AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 14 Jul 2022
Application
Utility: ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 24 Feb 2022
Application
Utility: ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 30 Dec 2021
Application
Utility: ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 6 May 2021
Application
Utility: SEPARATION MOIETIES AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 22 Apr 2021
Application
Utility: ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 10 Sep 2020
Application
Utility: ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 10 Sep 2020
Grant
Utility: Activatable interleukin-2 polypeptides External link
Filling date: 6 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Activatable interleukin 12 polypeptides External link
Filling date: 6 Sep 2025 Issue date: 30 Jun 2020
Application
Utility: ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 6 Feb 2020
Application
Utility: ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 5 Dec 2019

Showing 1 to 11 of 11 patents.